Login / Signup

Metronomic capecitabine combined with aromatase inhibitors for new chemoendocrine treatment of advanced breast cancer: a phase II clinical trial.

Jian-Wei LiWen-Jia ZuoDiana IvanovaXiao-Qing JiaLi LeiGuang-Yu Liu
Published in: Breast cancer research and treatment (2018)
Clinicaltrials.gov NCT01924078.
Keyphrases
  • phase ii
  • clinical trial
  • open label
  • phase iii
  • double blind
  • phase ii study
  • placebo controlled
  • locally advanced
  • radiation therapy
  • smoking cessation
  • breast cancer risk